PolyPeptide Group AG (SWX:PPGN)

Switzerland · Delayed Price · Currency is CHF

26.65

+2.15 (8.78%)

Mar 12, 2026, 5:30 PM CET

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Custom Projects	118.15M	154.45M	140.04M	167.01M	101.87M
Custom Projects Growth	-23.51%	10.29%	-16.14%	63.94%	20.86%
Contract Manufacturing	174.18M	135.39M	110.75M	89.60M	100.11M
Contract Manufacturing Growth	28.65%	22.24%	23.61%	-10.50%	0.61%
Generics and Cosmetics	44.47M	30.53M	30.18M	25.52M	21.05M
Generics and Cosmetics Growth	45.64%	1.17%	18.26%	21.22%	11.87%
Total	336.79M	320.37M	280.98M	282.13M	223.03M
Total Growth	5.13%	14.02%	-0.41%	26.50%	10.08%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Europe & India	242.37M	227.61M	-	-	-
Europe & India Growth	6.49%	-	-	-	-
USA	94.42M	92.76M	90.16M	89.89M	70.99M
USA Growth	1.79%	2.89%	0.30%	26.61%	24.60%
Europe & Asia	-	-	190.82M	192.24M	152.04M
Europe & Asia Growth	-	-	-0.74%	26.44%	4.40%
Total	336.79M	320.37M	280.98M	282.13M	223.03M
Total Growth	5.13%	14.02%	-0.41%	26.50%	10.08%

Source: S&P Global Market Intelligence.